Daily Runner

[Daily Runner @AtassiNazem]

SIRION signs license and collaboration agreement with Sanofi to develop improved tissue-selective AAV vectors to realize effective gene therapy treatments for disorders affecting major human organs. https://t.co/PQcpK9GKuq

[Daily Runner @AtassiNazem]

Written by my amazing classmate and friend Mehra.

[Daily Runner @AtassiNazem]

When a Cancer Surgeon Becomes a Cancer Patient by @MehraGolshan https://t.co/5GZ30cLmfe

[Osama Rahma @OsamaRahma2]

Very excited to release the beta version of our Outcomes4me app designed to empower breast cancer patients. Personalized NCCN guidelines-based treatment plan and precise trial matching. Get EARLY ACCESS to the app and help us shape this product:
https://t.co/BUj21QKMxE

[Merit cudkowicz @MeritCudkowicz]

@nicolecimbura @sheenachew @alsadvocacy @NEALSConsortium @PaganoniMDPhD @KNicholsonMD @AtassiNazem @BerryConsultant @statberry Als is actually pioneers in innovatio . First gene therapy trial for cns disorder, answer als, adaptive trials and more. But we must keep pushing and attracting best minds and more funds to cure als

[I AM ALS @iamalsorg]

Meet Brian. This is his story. He is an ALS patient. He is alive. He is fighting. He is determined to find a cure.

Join him today: https://t.co/01Uu5kLelK

And please RT. Thank you for daring to be awesome.

[Brian Wallach @bsw5020]

At 37, with two little kids, I was told I had ALS. No cure. 6 months to live.

That’s not how my story will end. I will see them get married. You and me, we’re going to rewrite the ALS story.

How?

1. Follow @iamalsorg
2. Retweet this post

Thank you for being great today.

[I AM ALS @iamalsorg]

There is no hope until there is. Today, I AM ALS launches. Today, we have more hope that a cure will be found. Together, we can. Join us: https://t.co/01Uu5ktCXa

[MGH Neurology @MGHNeurology]

Stephen Winthrop, a leader in raising awareness about ALS — and a patient, too — dies at 60 https://t.co/Ctip2zCHsF

[Jake Tapper 🦅 @jaketapper]

It started when he couldn’t grasp a pen. Diagnosed with ALS at 37, former Obama staffer hopes to use campaign skills to raise funds for a cure. - Chicago Tribune https://t.co/LFljAFb7A5

[Sheena Chew, MD @sheenachew]

Dr Suma Babu, showing us how it's done. Fantastic talk on spinal cord PET imaging biomarkers in #ALS. #alssymp @MGHNeurology @MeritCudkowicz @AtassiNazem

[60 Minutes @60Minutes]

“I think guys would be willing to take 10, 20 years off the end of their lives, in order to get out there on Sunday and play.” 22 years later, now diagnosed with ALS, former Atlanta Falcon Tim Green stands by that statement. Green tells his story, Sunday. https://t.co/dS77vHCXNA

[MGH Neurology @MGHNeurology]

Honored to team w/Tim to #TackleALS. Tune in Sun to hear Tim’s story, why Dr. Cudkowicz, Chief of Neurology & Director, Healey Center for ALS @ MGH, believes that w/proper funding & partnerships, therapy development will be accelerated for people w ALS living all over the world.

[Daily Runner @AtassiNazem]

Testing new drugs with “ALS-on-a-chip” https://t.co/n1rkK7iI0k

[AANEM @AANEMorg]

ALS, Frontotemporal Dementia Have Distinct Patterns of Brain Inflammation, Study Shows https://t.co/F8UtW4M1no

[NEALS Consortium @NEALSConsortium]

Registration is still open for the 2018 Annual NEALS Meeting in Clearwater Beach, FL held October 2-4. Learn more: https://t.co/KKhkILeASF

[Harvard Medical School @harvardmed]

Researchers have discovered tiny channels through the skull’s inner layer that carry inflammatory cells from marrow directly to the brain https://t.co/APdEoqMWd3

[Daily Runner @AtassiNazem]

Wonderful Feeling! I Just Ran the Falmouth 10K Race with #ALSONE to support #ALS Research 🏃🏃🏃 https://t.co/T7oRTJRgsX

[Joshua Cohen @JoshuaBCohen1]

New imaging study by @AtassiNazem and team at MGH! Really interesting results. #ALS #Imaging #Trials https://t.co/FZrmpE3Nx7

[NEALS Consortium @NEALSConsortium]

Did you miss today's #ALS webinar? Dr. Richard Bedlack @dukealsclinic reviewed the interesting background science on curcumin and outlined a new patient-centric clinical trial of a particular form of it that will occur at Duke University in 2019. https://t.co/v5TuvbcKLJ